2 min

Is Necitumumab An Effective Antibody Against EGFR for Patients with Squamous Lung Cancer‪?‬ GRACEcast Lung Cancer Video

    • Science

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

Dr. Nasser Hanna discusses the SQUIRE trial of the EGFR antibody Necitumumab in patients with squamous lung cancer. Though it achieved a statistical increase in OS, he does not consider it clinically relevant.

2 min

Top Podcasts In Science

NASA's Curious Universe
National Aeronautics and Space Administration (NASA)
Living Planet
DW
All About Radiotherapy
Cancer Research UK Cambridge Centre
Overheard at National Geographic
National Geographic
The Session with Tom Swarbrick
Global
Science Weekly
The Guardian

More by GRACEcast

GRACEcast Cancer 101 Video
cancerGRACE - H. Jack West, MD
GRACEcast Head and Neck Cancer Video NEW
cancerGRACE - H. Jack West, MD
GRACEcast Bladder Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Cancer 101 Audio
cancerGRACE - H. Jack West, MD
GRACEcast Kidney Cancer Video
cancerGRACE - H. Jack West, MD
GRACEcast Pancreatic Cancer Video
cancerGRACE - H. Jack West, MD